Status:
COMPLETED
Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension
Lead Sponsor:
Speedel Pharma Ltd.
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This study is conducted to investigate the effect of the oral renin inhibitor SPP635 on blood pressure in patients with mild to moderate hypertension.
Detailed Description
Renin-Angiotensin system blockade is a well established target for treatment of high blood pressure. Blocking the system at the initial step, however, is a rather new concept that could only be implem...
Eligibility Criteria
Inclusion
- male or female patients with mild to moderate hypertension
Exclusion
- female patients of child-bearing potential or breast-feeding
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00376636
Start Date
October 1 2006
End Date
May 1 2007
Last Update
October 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IKP Bobenheim GmbH
Mannheim, Germany, 68167